Cargando…

Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications

We sought to determine the effect of dipeptidyl peptidase IV (DPP-IV) inhibition on streptozotocin diabetes-induced vascular and neural dysfunction. After 4 weeks of untreated diabetes, rats were treated for 12 weeks with Alogliptin (DPP-IV inhibitor). Diabetes caused a slowing of motor and sensory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davidson, Eric P., Coppey, Lawrence J., Dake, Brian, Yorek, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142682/ https://www.ncbi.nlm.nih.gov/pubmed/21822422 http://dx.doi.org/10.1155/2011/810469

Ejemplares similares

Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model
por: Coppey, Lawrence, et al.
Publicado: (2019)

Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity
por: Davidson, Eric P., et al.
Publicado: (2011)

Effect of Treating Streptozotocin-Induced Diabetic Rats With Sorbinil, Myo-Inositol or Aminoguanidine on Endoneurial Blood Flow, Motor Nerve Conduction Velocity and Vascular Function of Epineurial Arterioles of the Sciatic Nerve
por: Coppey, Lawrence J., et al.
Publicado: (2002)

Partial Replacement with Menhaden Oil Improves Peripheral Neuropathy in High-Fat-Fed Low-Dose Streptozotocin Type 2 Diabetic Rat
por: Coppey, Lawrence J., et al.
Publicado: (2012)

Slowing of Motor Nerve Conduction Velocity in Streptozotocin-induced Diabetic Rats is Preceded by Impaired Vasodilation in Arterioles that Overlie the Sciatic Nerve
por: Coppey, Lawrence J., et al.
Publicado: (2000)

Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints
por: Holmes, Amey, et al.
Publicado: (2015)

Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688
por: Davidson, Eric P., et al.
Publicado: (2009)

The Roles of Streptozotocin Neurotoxicity and Neutral Endopeptidase in Murine Experimental Diabetic Neuropathy
por: Davidson, Eric, et al.
Publicado: (2009)

Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats
por: Davidson, Eric P., et al.
Publicado: (2018)

Determination of peripheral neuropathy in high‐fat diet fed low‐dose streptozotocin‐treated female C57Bl/6J mice and Sprague–Dawley rats
por: Coppey, Lawrence J, et al.
Publicado: (2018)

Characterization of Diabetic Neuropathy in the Zucker Diabetic Sprague-Dawley Rat: A New Animal Model for Type 2 Diabetes
por: Davidson, Eric P., et al.
Publicado: (2014)

Sensory Nerve Innervation of Epineurial Arterioles of the Sciatic Nerve Containing Calcitonin Gene–Related Peptide: Effect of Streptozotocin-Induced Diabetes
por: Yorek, M. A., et al.
Publicado: (2004)

Effect of dietary oils on peripheral neuropathy-related endpoints in dietary obese rats
por: Coppey, Lawrence, et al.
Publicado: (2018)

Progressive Loss of Corneal Nerve Fibers and Sensitivity in Rats Modeling Obesity and Type 2 Diabetes Is Reversible with Omega-3 Fatty Acid Intervention: Supporting Cornea Analyses as a Marker for Peripheral Neuropathy and Treatment
por: Coppey, Lawrence, et al.
Publicado: (2020)

Effect of Fidarestat and α-Lipoic Acid on Diabetes-Induced Epineurial Arteriole Vascular Dysfunction
por: Yorek, M. A., et al.
Publicado: (2004)

Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil
por: Coppey, Lawrence, et al.
Publicado: (2021)

Combination Therapies Prevent the Neuropathic, Proinflammatory Characteristics of Bone Marrow in Streptozotocin-Induced Diabetic Rats
por: Dominguez, James M., et al.
Publicado: (2015)

Corneal Sensitivity to Hyperosmolar Eye Drops: A Novel Behavioral Assay to Assess Diabetic Peripheral Neuropathy
por: Yorek, Matthew S., et al.
Publicado: (2016)

Dietary fats modify vascular fat composition, eNOS localization within lipid rafts and vascular function in obesity
por: Nuno, Daniel W., et al.
Publicado: (2018)

Effect of mitoquinone on liver metabolism and steatosis in obese and diabetic rats
por: Fink, Brian D., et al.
Publicado: (2021)

Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy
por: Obrosov, Alexander, et al.
Publicado: (2017)

Effect of Treatment with Salsalate, Menhaden Oil, Combination of Salsalate and Menhaden Oil, or Resolvin D1 of C57Bl/6J Type 1 Diabetic Mouse on Neuropathic Endpoints
por: Yorek, Matthew S., et al.
Publicado: (2016)

Immunohistochemical Pharmacokinetics of the Anti-diabetes Drug Alogliptin in Rat Kidney and Liver
por: Yamamoto, Yutaro, et al.
Publicado: (2020)

Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)

Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice
por: Coppey, Lawrence, et al.
Publicado: (2012)

Dolichos biflorus Linn. ameliorates diabetic complications in streptozotocin induced diabetic rats
por: Saxena, Yogesh, et al.
Publicado: (2014)

Catechin Treatment Ameliorates Diabetes and Its Complications in Streptozotocin-Induced Diabetic Rats
por: Samarghandian, Saeed, et al.
Publicado: (2017)

Dendrobium officinale Prevents Early Complications in Streptozotocin-Induced Diabetic Rats
por: Hou, Shao-zhen, et al.
Publicado: (2016)

The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus
por: Dudkowski, Caroline, et al.
Publicado: (2016)

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
por: Trammell, Samuel A.J., et al.
Publicado: (2016)

Functional and Immunofluorescence Evaluations of Vascular and Neural Integrities in Urinary Bladder of Streptozotocin-Induced Diabetic Mice
por: Kwon, Mi-Hye, et al.
Publicado: (2022)

The Attenuating Effect of Beta-Carotene on Streptozotocin Induced Diabetic Vascular Dementia Symptoms in Rats
por: Lim, Khian Giap, et al.
Publicado: (2022)

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2019)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Effects of metformin and alogliptin on body composition in people with type 2 diabetes
por: Takeshita, Yumie, et al.
Publicado: (2018)

Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus
por: Takeda, Hiroshi, et al.
Publicado: (2019)

Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus
por: Kaku, Kohei, et al.
Publicado: (2019)

Effects of Ribes khorasanicum hydro-ethanolic extract on streptozotocin-induced diabetic complications in rats
por: Gholamnezhad, Zahra, et al.
Publicado: (2021)

Effect of Inhibition or Deletion of Neutral Endopeptidase on Neuropathic Endpoints in High Fat Fed/Low Dose Streptozotocin-Treated Mice
por: Yorek, Matthew S., et al.
Publicado: (2016)

Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes
por: Sartoretto, JL, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ln7tdu95edfurjhvvtrhjqrfv9